Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
What happens if I am not approved for semaglutide
Smith, R
The Wegovy label notes increased hypoglycemia risk when semaglutide is used concomitantly with insulin or an insulin secretagogue, and states that use in type 1 diabetes or in combination with insulin has not been evaluated
Reported effects Significant body weight reduction (10-15% in trials) Improved glycemic control and reduced insulin resistance Reduced appetite and food cravings Potential cardiovascular benefits Convenient once-weekly dosing schedule Reported side effects Gastrointestinal issues (nausea, vomiting, diarrhea, constipation) Injection-site reactions (redness, swelling) Hypoglycemia (especially when combined with other diabetes medications) Rare serious risks: pancreatitis, gallbladder issues, kidney injury Thyroid C-cell tumors (observed in rodents) Storage Lyophilised (unmixed) Freeze at -20 C (-4 F) After reconstitution Refrigerate at 28 C (35.646.4 F), use within 28 days Supplies Important notes Always use a new, sterile insulin syringe for each injection and dispose of it properly in a sharps container
For an extra boost, consider using a hydrating toner or essence post-cleansing
US$ 25.90
US$ 21.10
US$ 24.11
US$ 29.77
